Hatem Azim, MD, chief medical officer at Emergence Therapeutics, and Marcela Mazo Canola, MD, breast medical oncologist at Mays Cancer Center at UT Health San Antonio, discuss if patients can interrupt endocrine therapy to attempt pregnancy.
▷ Estimated Read Time:
1–2 minutes
SABCS Snippets: Fertility preservation and assisted reproductive technologies
Join the global breast cancer community for four days of research spanning experimental biology, etiology, translational science, prevention, diagnosis and treatment, December 8-11 in San Antonio, Texas.
Share: